| Document Date: 2007-10-05 21:40:58
Open Document File Size: 37,80 KBShare Result on Facebook
Company John Wiley & Sons Inc. / Wilson / / Facility David L. Eaton University of Washington / University of Washington / National Institute of Environmental Health Sciences / / IndustryTerm molecular sequencing technology / exogenous chemicals / gene product / pharmaceutical industry / molecular laboratory tools / spliced protein products / chemical / drug-discovery pipeline technology / / MedicalCondition environmentally induced disease / specific diseases / cancer / disease / neurological disorders / important human diseases / diabetes / cardiovascular disease / section cover important disease / obesity / diseases / dehydrogenase deficiency / specific disease / infectious diseases / human diseases / immune and inflammatory response / neurodegenerative diseases / phenylketonuria / cystic fibrosis / chronic pulmonary diseases / asthma / / Organization National Institute of Health / National Institute of Environmental Health Sciences / University of Washington / Seattle / / Person David L. Eaton / Lucio G. Costa / Alan Roses / Arno G. Motulsky / Ken Olden / / Position director / / Product primaquine / / Technology genomics / pharmacogenetics / molecular sequencing technology / drug-discovery pipeline technology / genotyping / genotype / Human Genome / / URL http /
SocialTag |
Part I 1 Introduction Lucio G. Costa and David L. Eaton University of Washington, Seattle, WA